Diabetes-related foot ulceration (DFU) is a significant global health concern, affecting millions of individuals and placing substantial strain on healthcare systems. With nearly 34% of people with diabetes expected to develop foot ulcers during their lifetime, the need for effective and evidence-based interventions is paramount. However, variability in how studies report outcomes makes it challenging to compare interventions and develop consistent, effective treatment plans.
In an effort to address this, a new study led by an international team of experts, including David G. Armstrong, has developed a Core Outcome Set (COS) for research into diabetes-related foot ulceration. The study, published in Diabetes Care, offers a standardized set of eight key outcomes that should be consistently reported in all clinical trials and studies evaluating DFU treatments. These outcomes are:
- Wound healing
- Time to healing
- New/recurrent ulceration
- Infection
- Major amputation (above the ankle)
- Minor amputation (below the ankle)
- Health-related quality of life
- Mortality
The COS was developed using the rigorous Core Outcome Measures in Effectiveness Trials (COMET) methodology, which involved systematic reviews, patient interviews, and Delphi surveys of international experts and patients. The result is a set of outcomes that reflects both clinical relevance and the lived experiences of patients.
Why is this Important?
Heterogeneity in outcome reporting has long been a barrier to evaluating the comparative effectiveness of interventions for DFU. By implementing this core outcome set, researchers and clinicians will be able to make more meaningful comparisons between studies, ultimately improving patient care and outcomes.
For more information and to access the full study, you can find the manuscript here.
This work represents a significant step forward in ensuring that future research in this field is both patient-centered and clinically relevant, providing a foundation for more standardized, high-quality evidence that can shape treatment strategies and healthcare policy globally.
Leave a Reply